Meret Martin‐Facklam

2.0k total citations
38 papers, 1.5k citations indexed

About

Meret Martin‐Facklam is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Molecular Biology. According to data from OpenAlex, Meret Martin‐Facklam has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 10 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Meret Martin‐Facklam's work include Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Meret Martin‐Facklam is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Lung Cancer Treatments and Mutations (5 papers). Meret Martin‐Facklam collaborates with scholars based in Switzerland, Germany and United States. Meret Martin‐Facklam's co-authors include Walter E. Haefeli, Nahal Ketabi‐Kiyanvash, Johanna Weiß, Jürgen Burhenne, Neil Parrott, I. Walter‐Sack, Christiane Gasse, Daniela Alberati, Peter N. Morcos and Daniel Umbricht and has published in prestigious journals such as Journal of Clinical Oncology, NeuroImage and The American Journal of Medicine.

In The Last Decade

Meret Martin‐Facklam

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meret Martin‐Facklam Switzerland 21 322 314 266 255 198 38 1.5k
Caterina Palleria Italy 21 125 0.4× 255 0.8× 124 0.5× 224 0.9× 158 0.8× 75 1.5k
Francesco Rossi Italy 23 266 0.8× 219 0.7× 160 0.6× 161 0.6× 56 0.3× 112 1.7k
Mike Ufer Switzerland 25 331 1.0× 273 0.9× 86 0.3× 399 1.6× 381 1.9× 67 1.9k
Manuel Vaz‐da‐Silva Portugal 18 119 0.4× 278 0.9× 150 0.6× 194 0.8× 60 0.3× 61 1.2k
Véronique Michaud Canada 22 237 0.7× 246 0.8× 68 0.3× 180 0.7× 413 2.1× 71 1.3k
Brian Corrigan United States 23 115 0.4× 303 1.0× 121 0.5× 225 0.9× 184 0.9× 69 2.1k
Nicola Montanaro Italy 27 77 0.2× 601 1.9× 440 1.7× 138 0.5× 129 0.7× 97 2.2k
Y. W. Francis Lam United States 21 184 0.6× 191 0.6× 160 0.6× 300 1.2× 545 2.8× 74 1.7k
Eric J. F. Franssen Netherlands 25 727 2.3× 303 1.0× 84 0.3× 563 2.2× 102 0.5× 114 2.1k
Yoshito Zamami Japan 25 401 1.2× 450 1.4× 163 0.6× 54 0.2× 81 0.4× 174 2.1k

Countries citing papers authored by Meret Martin‐Facklam

Since Specialization
Citations

This map shows the geographic impact of Meret Martin‐Facklam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meret Martin‐Facklam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meret Martin‐Facklam more than expected).

Fields of papers citing papers by Meret Martin‐Facklam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meret Martin‐Facklam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meret Martin‐Facklam. The network helps show where Meret Martin‐Facklam may publish in the future.

Co-authorship network of co-authors of Meret Martin‐Facklam

This figure shows the co-authorship network connecting the top 25 collaborators of Meret Martin‐Facklam. A scholar is included among the top collaborators of Meret Martin‐Facklam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meret Martin‐Facklam. Meret Martin‐Facklam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hutchinson, Lucy, et al.. (2025). PD‐1‐Cis IL‐2R Agonism Determines the Predicted Pharmacological Dose Range for the Immunocytokine Eciskafusp Alfa (PD1‐IL2v). CPT Pharmacometrics & Systems Pharmacology. 14(12). 2128–2138. 1 indexed citations
2.
Lotz, Gregor P., Meret Martin‐Facklam, Eginhard Schick, et al.. (2024). Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure. Frontiers in Immunology. 15. 1406353–1406353. 1 indexed citations
3.
Bray‐French, Katharine, Guido Steiner, Juliana Bessa, et al.. (2021). Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside. Journal of Pharmaceutical Sciences. 110(7). 2575–2584. 20 indexed citations
4.
Jankovic, Joseph, Ira Goodman, Beth Safirstein, et al.. (2018). Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease. JAMA Neurology. 75(10). 1206–1206. 224 indexed citations
5.
Fowler, Stephen, Peter N. Morcos, Yumi Cleary, et al.. (2017). Progress in Prediction and Interpretation of Clinically Relevant Metabolic Drug-Drug Interactions: a Minireview Illustrating Recent Developments and Current Opportunities. Current Pharmacology Reports. 3(1). 36–49. 36 indexed citations
6.
Hofmann, Carsten, Christophe Boetsch, Daniela Alberati, et al.. (2016). Effects of the glycine reuptake inhibitors bitopertin and RG7118 on glycine in cerebrospinal fluid: results of two proofs of mechanism studies in healthy volunteers. Psychopharmacology. 233(13). 2429–2439. 21 indexed citations
7.
Hsu, Joy, Volkmar Henschel, Katrijn Bogman, et al.. (2016). Population pharmacokinetics (popPK) and exposure-response (ER) analyses to confirm alectinib 600 mg BID dose selection in a crizotinib-progressed or intolerant population.. Journal of Clinical Oncology. 34(15_suppl). e20598–e20598. 15 indexed citations
8.
Parrott, Neil, et al.. (2014). Physiologically Based Absorption Modelling to Predict the Impact of Drug Properties on Pharmacokinetics of Bitopertin. The AAPS Journal. 16(5). 1077–1084. 26 indexed citations
9.
Parrott, Neil, Dominik Hainzl, Daniela Alberati, et al.. (2013). Physiologically Based Pharmacokinetic Modelling to Predict Single- and Multiple-Dose Human Pharmacokinetics of Bitopertin. Clinical Pharmacokinetics. 52(8). 673–683. 15 indexed citations
10.
Martin‐Facklam, Meret, Yun Zhou, Susanne Ostrowitzki, et al.. (2012). Glycine Transporter Type 1 Occupancy by Bitopertin: a Positron Emission Tomography Study in Healthy Volunteers. Neuropsychopharmacology. 38(3). 504–512. 36 indexed citations
11.
Hofmann, Carsten, et al.. (2012). Evaluation of the Effects of Bitopertin (RG1678) on Cardiac Repolarization: A Thorough Corrected QT Study in Healthy Male Volunteers. Clinical Therapeutics. 34(10). 2061–2071. 13 indexed citations
12.
Wong, Dean F., Susanne Ostrowitzki, Yun Zhou, et al.. (2011). Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans. NeuroImage. 75. 282–290. 17 indexed citations
13.
Martin‐Facklam, Meret, Jürgen Drewe, & Walter E. Haefeli. (2008). Arzneimittel-Interaktionen am Cytochrom-P450-System. DMW - Deutsche Medizinische Wochenschrift. 125(3). 63–67. 2 indexed citations
14.
Haefeli, Walter E., et al.. (2005). Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature. European Journal of Clinical Pharmacology. 61(5-6). 327–335. 60 indexed citations
15.
Martin, Peter, Walter E. Haefeli, & Meret Martin‐Facklam. (2004). A Drug Database Model as a Central Element for Computer-Supported Dose Adjustment within a CPOE System. Journal of the American Medical Informatics Association. 11(5). 427–432. 15 indexed citations
16.
Martin‐Facklam, Meret, et al.. (2004). Undeclared exposure to St. John's Wort in hospitalized patients. British Journal of Clinical Pharmacology. 58(4). 437–441. 26 indexed citations
17.
Fröhlich, Margit, Jürgen Burhenne, Meret Martin‐Facklam, et al.. (2004). Oral Contraception Does Not Alter Single Dose Saquinavir Pharmacokinetics in Women. British Journal of Clinical Pharmacology. 57(3). 244–252. 24 indexed citations
18.
Weiß, Johanna, et al.. (2003). Inhibition of P-Glycoprotein by Newer Antidepressants. Journal of Pharmacology and Experimental Therapeutics. 305(1). 197–204. 244 indexed citations
19.
Haefeli, Walter E., et al.. (2001). Drug dosage in patients with renal failure optimized by immediate concurrent feedback. Journal of General Internal Medicine. 16(6). 369–375. 74 indexed citations
20.
Mandelbaum, A, et al.. (2000). Unexplained decrease of cyclosporin trough levels in a compliant renal transplant patient. Nephrology Dialysis Transplantation. 15(9). 1473–1474. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Palleria Breakdown of academic impact, for papers by Francesco Rossi Breakdown of academic impact, for papers by Mike Ufer Breakdown of academic impact, for papers by Manuel Vaz‐da‐Silva Breakdown of academic impact, for papers by Véronique Michaud Breakdown of academic impact, for papers by Brian Corrigan Breakdown of academic impact, for papers by Nicola Montanaro Breakdown of academic impact, for papers by Y. W. Francis Lam Breakdown of academic impact, for papers by Eric J. F. Franssen Breakdown of academic impact, for papers by Yoshito Zamami
Rankless by CCL
2026